Sacramento, Calif.-based UC Davis Health has received a $2.8 million grant from the National Institute of Biomedical Imaging and Bioengineering and National Institutes of Health to develop an AI-based digital pathology tool for use in cell therapy research.
The four-year project will study how mesenchymal stem cell therapy impacts chronic inflammatory diseases. Researchers will examine how stem cells modulate immune responses and whether enhanced or nonviable cells offer similar benefits, according to a Sept. 19 news release.
The grant will also be used to build an inflammation digital pathology tool, an AI-powered platform to help pathologists more objectively quantify tissue damage. The team will pull from a database of 700 digitized histopathology slides from mouse models and plans to expand the dataset to more than 1,000 samples.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.